Open AccessIntravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy*
Author(s) -
Ahmet Hondur,
Mehmet Özgür Çubuk,
Zühal Özen Tunay,
Hatice Tuba Atalay,
Özdemir Özdemir,
İkbal Seza Petriçli,
İhsan Gökhan Gürelik
Publication year - 2016
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1502-65
Subject(s) - medicine , retinopathy of prematurity , bevacizumab , ophthalmology , dioptre , strabismus , laser coagulation , surgery , visual acuity , chemotherapy , gestational age , pregnancy , genetics , biology
To evaluate refractive and strabismic results and the efficacy of intravitreal bevacizumab in retinopathy of prematurity (ROP) ineligible for laser therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom